Advisory Research Inc Novo Nordisk A S Transaction History

Advisory Research Inc

  • $512 Million
  • Q3 2024

A detailed history of Advisory Research Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Advisory Research Inc holds 2,267 shares of NVO stock, worth $244,858. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,267
Previous 3,342 32.17%
Holding current value
$244,858
Previous $477,000 43.61%
% of portfolio
0.05%
Previous 0.1%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $128,000 - $156,326
-1,075 Reduced 32.17%
2,267 $269,000
Q2 2024

Aug 13, 2024
BUY
$122.71 - $146.91 $126,145 - $151,023
1,028 Added 44.43%
3,342 $477,000
Q1 2024

May 14, 2024
SELL
$102.11 - $135.92 $709,460 - $944,372
-6,948 Reduced 75.02%
2,314 $297,000
Q4 2023

Feb 13, 2024
BUY
$87.78 - $105.45 $34,760 - $41,758
396 Added 4.47%
9,262 $958,000
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $155,689 - $341,612
1,712 Added 23.93%
8,866 $806,000
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $262,358 - $290,397
1,682 Added 30.74%
7,154 $1.16 Million
Q1 2023

May 12, 2023
BUY
$132.34 - $159.14 $181,835 - $218,658
1,374 Added 33.53%
5,472 $870,000
Q4 2022

Feb 13, 2023
BUY
$102.55 - $135.33 $18,971 - $25,036
185 Added 4.73%
4,098 $554,000
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $138,251 - $169,665
1,451 Added 58.94%
3,913 $390,000
Q2 2022

Aug 17, 2022
BUY
$103.24 - $121.81 $10,014 - $11,815
97 Added 4.1%
2,462 $274,000
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $155,477 - $187,941
-1,670 Reduced 41.39%
2,365 $263,000
Q4 2021

Feb 11, 2022
SELL
$95.88 - $117.08 $4,506 - $5,502
-47 Reduced 1.15%
4,035 $452,000
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $47,950 - $60,560
568 Added 16.16%
4,082 $392,000
Q1 2021

May 12, 2021
SELL
$67.06 - $75.82 $303,513 - $343,161
-4,526 Reduced 56.29%
3,514 $237,000
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $208,920 - $241,326
3,270 Added 68.55%
8,040 $562,000
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $2,866 - $3,159
-45 Reduced 0.93%
4,770 $331,000
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $61,115 - $70,929
-1,044 Reduced 17.82%
4,815 $315,000
Q1 2020

May 12, 2020
SELL
$49.46 - $64.78 $17,113 - $22,413
-346 Reduced 5.58%
5,859 $353,000
Q4 2019

Feb 11, 2020
BUY
$49.86 - $58.26 $309,381 - $361,503
6,205 New
6,205 $359,000

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email